Journal of Chinese Integrative Medicine ›› 2009, Vol. 7 ›› Issue (9): 873-.doi: 10.3736/jcim20090914
• Literature Review • Previous Articles Next Articles
Shen Zhang),Hui-ming Lin, Ping-kang Wei
[1] |
Harvey KB, Bothe JA, Blackburn GL . Nutritional assessment and patient outcome during oncological therapy[J]. Cancer, 1979,43(5 Suppl):2065-2069
doi: 10.1002/(ISSN)1097-0142 |
[2] |
Inui A . Cancer anorexia-cachexia syndrome: current issues in research and management[J]. CA Cancer J Clin, 2002,52(2):72-91
doi: 10.3322/canjclin.52.2.72 pmid: 11929007 |
[3] |
MacDonald N, Easson AM, Mazurak VC, Dunn GP, Baracos VE . Understanding and managing cancer cachexia[J]. J Am Coll Surg, 2003,197(1):143-161
doi: 10.1016/S1072-7515(03)00382-X pmid: 12831935 |
[4] | Lesniak W , Bała M, Jaeschke R, Krzakowski M. Effects of megestrol acetate in patients with cancer anorexia-cachexia syndrome—a systematic review and meta-analysis[J]. Pol Arch Med Wewn, 2008,118(11):636-644 |
[5] |
Argilés JM, Alvarez B, López-Soriano FJ . The metabolic basis of cancer cachexia[J]. Med Res Rev, 1997,17(5):477-498
doi: 10.1002/(SICI)1098-1128(199709)17:53.3.CO;2-Q pmid: 9276862 |
[6] |
Argilés JM, Alvarez B, López-Soriano FJ . The pivotal role of cytokines in muscle wasting during cancer[J]. Int J Biochem Cell Biol, 2005,37(10):2036-2046
doi: 10.1016/j.biocel.2005.03.014 pmid: 15878837 |
[7] |
Argilés JM, Alvarez B, López-Soriano FJ . Molecular mechanisms involved in muscle wasting in cancer and aging: cachexia versus sarcopenia[J]. Int J Biochem Cell Biol, 2005,37(5):1084-1104
doi: 10.1016/j.biocel.2004.10.003 |
[8] |
Cui HJ, Li PW, Li Y, Tan HY, Zhao W . Syndrome differentiation of lung cancer cachexia in traditional Chinese medicine[J]. Neimenggu Zhong Yi Yao, 2002,21(5):1-2
doi: 10.3969/j.issn.1006-0979.2002.05.001 |
崔慧娟, 李佩文, 李园, 谭煌英, 赵炜 . 肺癌恶病质的中医辨证分型[J]. 内蒙古中医药, 2002,21(5):1-2
doi: 10.3969/j.issn.1006-0979.2002.05.001 |
|
[9] |
Shen WX, Liu YM . Mechanisms of cytokine network and traditional Chinese herbal medicine[J]. Shi Jie Ke Xue Ji Shu Zhong Yao Xian Dai Hua, 2000,2(6):24-27
doi: 10.11842/wst.2000.6.[sequence] |
申维玺, 刘玉梅 . 细胞因子网络与中药的作用机理[J]. 世界科学技术: 中药现代化, 2000,2(6):24-27
doi: 10.11842/wst.2000.6.[sequence] |
|
[10] | Shen WX, Sun Y, Zhang SR, Yu GQ . Relationship between cytokine interleukin-1 and lung yin deficiency[J]. Zhong Yi Za Zhi, 2000,41(7):423-425 |
申维玺, 孙燕, 张叔人, 余桂清 . 白细胞介素-1等细胞因子与肺阴虚证本质的相关性研究[J]. 中医杂志, 2000,41(7):423-425 | |
[11] | Shen WX, Sun Y . Disordered cytokine network is basic mechanism of pathogenesis[J]. Yi Xue Yan Jiu Tong Xun, 2000,29(7):8-12 |
申维玺, 孙燕 . 细胞因子网络紊乱是疾病的基本发病学机制[J]. 医学研究通讯, 2000,29(7):8-12 | |
[12] | Han MJ, Gong XH, Wang SL, Zhang D, Zhao CH . Study on the relationship between the serum level of TNF-α and yin deficiency[J]. Dalian Da Xue Xue Bao, 2005,26(4):76-78 |
韩美君, 宫晓虹, 王善利, 张丹, 赵彩虹 . TNF-α与中医阴虚证相关性的研究[J]. 大连大学学报, 2005,26(4):76-78 | |
[13] |
Jiang J . Clinical observation of Kanglaite Injection in treatment of 37 cases of advanced cancer cachexia[J]. Qinghai Yi Yao Za Zhi, 2001,31(9):16-18
doi: 10.3969/j.issn.1007-3795.2001.09.008 |
姜军 . 康莱特注射液治疗晚期癌症恶病质37例临床观察[J]. 青海医药杂志, 2001,31(9):16-18
doi: 10.3969/j.issn.1007-3795.2001.09.008 |
|
[14] |
Han GD, Li HS, Wang J . Effects of Kanglaite on cachexia and immune function of the patients with advanced cancer[J]. Jiangxi Zhong Yi Yao, 2006,37(8):20-21
doi: 10.3969/j.issn.0411-9584.2006.08.012 |
韩国栋, 李洪胜, 王建 . 康莱特对晚期恶性肿瘤患者恶病质和免疫功能的影响[J]. 江西中医药, 2006,37(8):20-21
doi: 10.3969/j.issn.0411-9584.2006.08.012 |
|
[15] |
Zhao ZR . Combination of Kanglaite and radiotherapy in the treatment of advanced cancer patients[J]. Xian Dai Zhong Liu Yi Xue, 2005,13(1):71-72
doi: 10.3969/j.issn.1672-4992.2005.01.031 |
赵忠仁 . 康莱特联合放疗治疗中晚期恶性肿瘤的临床研究[J]. 现代肿瘤医学, 2005,13(1):71-72
doi: 10.3969/j.issn.1672-4992.2005.01.031 |
|
[16] | Zhou Y, He J, Liu XR . The Kanglaite Injection combined with exterior gastric intestinal nutrition for the treatment of cachexia with cancer[J]. Zhongguo Zhong Liu, 2006,15(9):635-636 |
周毅, 何捷, 刘旭荣 . 康莱特注射液配合胃肠外营养治疗癌症恶液质[J]. 中国肿瘤, 2006,15(9):635-636 | |
[17] |
Cai HP, Xie WF, Chen YX, Zhang XR, Deng ZH, Li S, Shen JW . Effect of As2O3 on cancer cachexia with colorectal cancer metastasis to abdominal cavity in nude mice[J]. Di Er Jun Yi Da Xue Xue Bao, 2002,23(3):279-280
doi: 10.3321/j.issn:0258-879X.2002.03.015 |
蔡洪培, 谢渭芬, 陈岳祥, 张兴荣, 邓志华, 李石, 沈建伟 . 三氧化二砷对腹腔荷瘤裸鼠的抗恶病质效应[J]. 第二军医大学学报, 2002,23(3):279-280
doi: 10.3321/j.issn:0258-879X.2002.03.015 |
|
[18] |
Jia YS, Wu SQ, Qin ZQ . Clinical analysis of bruceolic oil emulsion combined with intervention therapy in treatment of primary liver cancer[J]. Zhongguo Zhong Yao Za Z, 2003,28(7):683-684.
doi: 10.3321/j.issn:1001-5302.2003.07.031 |
贾勇士, 吴树强, 钦志泉 . 鸦胆子油乳配合介入治疗原发性肝癌的临床分析[J]. 中国中药杂志, 2003,28(7):683-684.
doi: 10.3321/j.issn:1001-5302.2003.07.031 |
|
[19] |
Xu YQ, Xue HN, Zou J . Short-term efficacy and toxicity of compound Kushen Injection combined with chemotherapy on advanced tumor[J]. Anhui Zhong Yi Lin Chuang Za Zhi, 2001,13(3):160-162
doi: 10.3969/j.issn.1672-7134.2001.03.002 |
许尤琪, 薛惠宁, 邹军 . 复方苦参注射液联合化疗治疗恶性肿瘤近期疗效和毒副作用观察[J]. 安徽中医临床杂志, 2001,13(3):160-162
doi: 10.3969/j.issn.1672-7134.2001.03.002 |
|
[20] | Liu JB , Yao ZW. Clinical effects of Hedyotis diffusa Injection on primary liver cancer[J]. Yi Yao Lun Tan Za Zhi, 2004, 25(15): 37, 39 |
刘俊保, 姚志伟 . 白花蛇舌草注射液对原发性肝癌的临床作用[J].医药论坛杂志, 2004, 25(15): 37, 39 | |
[21] |
Huang T, Chen Z, Li Y . Experimental study of the anti-tumor activity and effect of Shenmai Liquid on glycometabolism[J]. Zhong Cheng Yao, 2003,25(5):390-393
doi: 10.3969/j.issn.1001-1528.2003.05.017 |
黄挺, 陈震, 李勇 . 参麦液抗肿瘤作用及其对糖代谢的影响[J]. 中成药, 2003,25(5):390-393
doi: 10.3969/j.issn.1001-1528.2003.05.017 |
|
[22] |
Ge CH, Fan CM, Wang SW, Chen Y, Gu WJ, Chen B . Effect of Shengmai Injection combined with chemotherapy on postoperative patients with gastric carcinoma[J]. Yao Xue Fu Wu Yu Yan Jiu, 2005,5(3):292-295
doi: 10.3969/j.issn.1671-2838.2005.03.023 |
葛成华, 范成美, 王世伟, 陈晔, 顾文军, 陈炳 . 生脉注射液在胃癌根治术后化疗中的作用[J]. 药学服务与研究, 2005,5(3):292-295
doi: 10.3969/j.issn.1671-2838.2005.03.023 |
|
[23] |
Cui HJ, Li Y, Wan DG, Wu XQ, Hao YX, Jia LQ, Huang J, Yu LL . Clinical study on anti-cancer cachexia of Shenfu Injection[J]. Zhongguo Zhong Liu Lin Chuang Yu Kang Fu, 2005,12(5):478-480
doi: 10.3969/j.issn.1005-8664.2005.05.044 |
崔慧娟, 李园, 万冬桂, 武晓勤, 郝迎旭, 贾立群, 黄静, 于莉莉 . 参附注射液抗癌症恶病质的临床研究[J]. 中国肿瘤临床与康复, 2005,12(5):478-480
doi: 10.3969/j.issn.1005-8664.2005.05.044 |
|
[24] |
Yang YF, Wu Y, Wu DH . Anti-cancer cachexia of Shenfu Injection by gene chip study[J]. Zhongguo Shi Yan Fang Ji Za Zhi, 2001,10(2):22-25
doi: 10.3969/j.issn.1005-9903.2004.02.010 |
杨宇飞, 吴煜, 邬冬华 . 参附注射液抗癌症恶病质基因芯片研究[J]. 中国实验方剂杂志, 2001,10(2):22-25
doi: 10.3969/j.issn.1005-9903.2004.02.010 |
|
[25] |
Liu Y, Ye F, Qiu GQ, Zhang M, Wang R, He QY, Cai Y . Effects of lactone Ⅰ from Atractylodes macrocephala Koidz on cytokines and proteolysis-inducing factors in cachectic cancer patients[J]. Di Yi Jun Yi Da Xue Xue Bao, 2005,25(10):1308-1311
doi: 10.3321/j.issn:1673-4254.2005.10.030 |
刘昳, 叶峰, 邱根全, 章梅, 王锐, 何群英, 蔡云 . 白术内酯Ⅰ对肿瘤恶病质患者细胞因子和肿瘤代谢因子的影响[J]. 第一军医大学学报, 2005,25(10):1308-1311
doi: 10.3321/j.issn:1673-4254.2005.10.030 |
|
[26] |
Wu SS, Gao WY, Duan HQ, Jia W . Advances in studies on chemical constituents and pharmacological activities of Rhizoma Paridis[J]. Zhong Cao Yao, 2004,35(3):344-347
doi: 10.7501/j.issn.0253-2670.2004.3.149 |
武珊珊, 高文远, 段宏泉, 贾伟 . 重楼化学成分和药理作用研究进展[J]. 中草药, 2004,35(3):344-347
doi: 10.7501/j.issn.0253-2670.2004.3.149 |
|
[27] | Xu S, Hu JH, Quan SC . Active ingredients of Angelica dahurica and progress of their clinical application[J]. Zhongguo Yao Fang, 2005,16(6):467-469 |
徐术, 胡晋红, 全山丛 . 白芷的活性成分研究与临床应用进展[J]. 中国药房, 2005,16(6):467-469 | |
[28] |
Zhang J . Effects of traditional Chinese herbal medicine on cachexia status of cancer patients[J]. Zhongguo Zhong Xi Yi Jie He Za Zhi, 2007,20(11):871
doi: 10.7661/CJIM.2000.11.871 |
张静 . 中药对癌症患者恶病质状态的影响[J]. 中国中西医结合杂志, 2007,20(11):871
doi: 10.7661/CJIM.2000.11.871 |
|
[29] |
Cai HB, Luo RC, Yang CB, Pan CH, Zuo Q, Wang YG . Buzhong Yiqi Tang for carcinomatous anorexia-cachexia syndrome: a clinical observation of 30 cases[J]. Xin Zhong Yi, 2003,35(3):25-26
doi: 10.3969/j.issn.0256-7415.2003.03.012 |
蔡红兵, 罗荣城, 杨传标, 潘春华, 左强, 王月刚 . 补中益气汤治疗癌症食欲不振-恶病质综合征30例疗效观察[J]. 新中医, 2003,35(3):25-26
doi: 10.3969/j.issn.0256-7415.2003.03.012 |
|
[30] | Wang SF, Zhang F . Clinical observation of syndrome differentiation treatment combined with low-dose chemotherapy in treatment of advanced primary liver cancer[J]. Neimenggu Zhong Yi Yao, 2000,19(4):2-3 |
王守峰, 张峰 . 中医辨证配合小剂量化疗治疗晚期原发性肝癌疗效观察[J]. 内蒙古中医药, 2000,19(4):2-3 | |
[31] |
Geng DS . Study progress of Shiquan Dabu Decoction[J]. Zhong Cheng Yao, 2003,25(10):837-840
doi: 10.3969/j.issn.1001-1528.2003.10.023 |
耿东升 . 十全大补汤研究进展[J]. 中成药, 2003,25(10):837-840
doi: 10.3969/j.issn.1001-1528.2003.10.023 |
|
[32] |
Xu L, Chen YL, Liu YY, Qin ZF, Li J, Shi J . Clinical observation of Jinlongshe Oral Liquid combined with Huachansu Injection and Huangqi Injection in treatment of stage Ⅳgastric cancer[J]. Chengdu Zhong Yi Yao Da Xue Xue Bao, 2005,28(1):7-9
doi: 10.3969/j.issn.1004-0668.2005.01.003 |
许玲, 陈亚琳, 刘咏英, 秦志丰, 李峻, 施俊 . 金龙蛇口服液合华蟾素注射液、黄芪注射液治疗Ⅳ期胃癌的临床观察[J]. 成都中医药大学学报, 2005,28(1):7-9
doi: 10.3969/j.issn.1004-0668.2005.01.003 |
|
[33] |
Li XY, Wei PK . Clinical observation of Jinlongshe Oral Liquid in treatment of advanced gastric cancer[J]. Hubei Zhong Yi Za Zhi, 2001,23(11):7-9
doi: 10.3969/j.issn.1000-0704.2001.11.001 |
李相勇, 魏品康 . 金龙蛇口服液治疗晚期胃癌的疗效观察[J]. 湖北中医杂志, 2001,23(11):7-9
doi: 10.3969/j.issn.1000-0704.2001.11.001 |
|
[34] |
Sun T, Wang SG, Wu FX, Li CH, Zhang DW . Clinical study on the treatment of tumor cachexia with composite Shougong Powder[J]. Anhui Zhong Yi Xue Yuan Xue Bao, 2003,22(8):19-20
doi: 10.3969/j.issn.1000-2219.2003.06.009 |
孙彤, 王曙光, 吴飞雪, 李崇慧, 张东伟 . 复方守宫散治疗肿瘤恶病质的临床研究[J]. 安徽中医学院学报, 2003,22(8):19-20
doi: 10.3969/j.issn.1000-2219.2003.06.009 |
[1] | Tara Rajendran. Addressing the need for personalizing music therapy in integrative oncology. Journal of Integrative Medicine, 2022, 20(4): 281-283. |
[2] | Wan-jun Guo, Yi Wang, Yu Deng, Lin-yan Cheng, Xin Liu, Ruo-fan Xi, Sheng-jie Zhu, Xin-yi Feng, Liang Hua, Kan Ze, Jian-yong Zhu, Dong-jie Guo, Fu-lun Li. Therapeutic effects of the extract of Sancao Formula, a Chinese herbal compound, on imiquimod-induced psoriasis via cysteine-rich protein 61. Journal of Integrative Medicine, 2022, 20(4): 376-384. |
[3] | Tara Rajendran, Martha Summa-Chadwick. The scope and potential of music therapy in stroke rehabilitation. Journal of Integrative Medicine, 2022, 20(4): 284-287. |
[4] | Shang-jin Song, Xuan Liu, Qing Ji, Da-zhi Sun, Li-juan Xiu, Jing-yu Xu, Xiao-qiang Yue. Ziyin Huatan Recipe, a Chinese herbal compound, inhibits migration and invasion of gastric cancer by upregulating RUNX3 expression. Journal of Integrative Medicine, 2022, 20(4): 355-364. |
[5] | Lu Yin, Yun An, Xiao Chen, Hui-xin Yan, Tao Zhang, Xin-gang Lu, Jun-tao Yan. Local vibration therapy promotes the recovery of nerve function in rats with sciatic nerve injury. Journal of Integrative Medicine, 2022, 20(3): 265-273. |
[6] | Marisa Casal. Improving the health and treatment success rates of in vitro fertilization patients with traditional chinese medicine: need for more robust evidence and innovative approaches. Journal of Integrative Medicine, 2022, 20(3): 187-192. |
[7] | Ning Guo, Fei Wu, Mei Wu, Yuan Wang, Qing Lang, Xiao Lin, Yi Feng. Progress in the design and quality control of placeboes for clinical trials of traditional Chinese medicine . Journal of Integrative Medicine, 2022, 20(3): 204-212. |
[8] | Yan-jun Lin, Kun-li Jiao, Bo Liu, Lu Fang, Shu Meng. Antiplatelet and myocardial protective effect of shexiang tongxin dropping pill in patients undergoing percutaneous coronary intervention: A randomized controlled trial. Journal of Integrative Medicine, 2022, 20(2): 126-134. |
[9] | Bin Zhao, Yong Chen, Shi-min Liao, Jian-ying Zheng, Shi-hua Yan, Dong-shu Zhang. Successfully treated recalcitrant atopic eczema with acupoint autohemotherapy: A case report and hypothesized mechanism of the therapy. Journal of Integrative Medicine, 2022, 20(2): 182-186. |
[10] |
Mohamed S. Othman, Sofian T. Obeidat, Amal H. Al-Bagawi, Mohamed A. Fareid, Alaa Fehaid, Ahmed E. Abdel Moneim.
Green-synthetized selenium nanoparticles using berberine as a promising anticancer agent#br#
#br#
. Journal of Integrative Medicine, 2022, 20(1): 65-72.
|
[11] | Jia-jia Li, Qing Liang, Guang-chun Sun. Traditional Chinese medicine for prevention and treatment of hepatocellular carcinoma: A focus on epithelial-mesenchymal transition. Journal of Integrative Medicine, 2021, 19(6): 469-477. |
[12] | Shu-yi Chen, Qun-wei Chen, Liu-mei Shou, Hong Pan, Shan-ming Ruan, Zhe-hao Liang, Qi-jin Shu. Stevens-Johnson syndrome/toxic epidermal necrolysis successfully treated with Chinese herbal medicine Pi-Yan-Ning: A case report. Journal of Integrative Medicine, 2021, 19(6): 555-560. |
[13] | Gai Ran, Xi-lin Feng, Yi-lin Xie, Qing-yun Zheng, Peng-peng Guo, Ming Yang, Ying-lu Feng, Chen Ling, Li-qing Zhu, Chen Zhong. The use of miR122 and its target sequence in adeno-associated virus-mediated trichosanthin gene therapy. Journal of Integrative Medicine, 2021, 19(6): 515-525. |
[14] | Mao-xing Pan, Chui-yang Zheng, Yuan-jun Deng, Kai-rui Tang, Huan Nie, Ji-qian Xie, Dong-dong Liu, Gui-fang Tu, Qin-he Yang, Yu-pei Zhang. Hepatic protective effects of Shenling Baizhu powder, a herbal compound, against inflammatory damage via TLR4/NLRP3 signalling pathway in rats with nonalcoholic fatty liver disease . Journal of Integrative Medicine, 2021, 19(5): 428-438. |
[15] | Xin Yin, Shu-bin Cai, Lan-ting Tao, Lu-ming Chen, Zhong-de Zhang, Su-hong Xiao, Arthur Yin Fan, Xu Zou. Recovery of a patient with severe COVID-19 by acupuncture and Chinese herbal medicine adjuvant to standard care. Journal of Integrative Medicine, 2021, 19(5): 460-466. |
|